ResearchTyrer-Cuzick Lifetime Risk Is Not Associated With Non-BRCA1/2 Pathogenic Variants for Breast Carcinoma
ResearchNeoadjuvant Chemotherapy for T3 Tumors in the Era of Precision Medicine—Biology Is Still King
ResearchUtilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes
ResearchAuthors' Reply to the Letter to the Editor by Stimac and Bayley: Utilization of Cancer Screening, Prevention, and Treatment in Women With Variants of Uncertain Significance in Breast Cancer Susceptibility Genes
ResearchCascade Testing for Hereditary Cancer: Comprehensive Multigene Panels Identify Unexpected Actionable Findings in Relatives
ResearchNeoadjuvant Chemotherapy and Immunotherapy for Estrogen Receptor-Positive Human Epidermal Growth Factor 2-Negative Breast Cancer
ResearchAge-Independent Preoperative Chemosensitivity and 5-Year Outcome Determined by Combined 70- and 80-Gene Signature in a Prospective Trial in Early-Stage Breast Cancer
ResearchDistinct Neoadjuvant Chemotherapy Response and 5-Year Outcome in Patients With Estrogen Receptor-Positive, Human Epidermal Growth Factor 2-Negative Breast Tumors That Reclassify as Basal-Type by the 80-Gene Signature
ResearchClinical Impact of Intraoperative Margin Assessment in Breast-Conserving Surgery With a Novel Pegulicianine Fluorescence-Guided System: A Nonrandomized Controlled Trial
ResearchTherapeutic Value of Sentinel Lymph Node Biopsy in Patients With Melanoma: A Randomized Clinical Trial
ResearchGenomic Classification of HER2-Positive Patients With 80-Gene and 70-Gene Signatures Identifies Diversity in Clinical Outcomes With HER2-Targeted Neoadjuvant Therapy
ResearchCombined 70- and 80-Gene Signatures Identify Tumors With Genomically Luminal Biology Responsive to Neoadjuvant Endocrine Therapy and Are Prognostic of 5-Year Outcome in Early-Stage Breast Cancer
ResearchPreoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does Not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial
ResearchIntegrating 31-Gene Expression Profiling With Clinicopathologic Features to Optimize Cutaneous Melanoma Sentinel Lymph Node Metastasis Prediction